Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole-assisted ovarian stimulation for fertility preservation in breast cancer patients
2012-003412-31Phase 4Completed
- Sponsor
- Erasmus Hospital
- Start
- Sep 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of letrozole in breast cancer (2 arms), sponsored by Erasmus Hospital. Primary endpoints: Feasibility and efficiency of ovarian stimulation protocol and Oocyte maturation rate comparison. Started Sep 2012; status: completed.
02
Drugs
letrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2012-003412-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003412-31.